BETHESDA — Spherix Inc. of Bethesda, said it cut its second-quarter net loss to $1 million, or 40 cents per diluted share, versus a net loss of $2.6 million, or $1.49 per share, for the year-ago period. Revenue in the ...
Tagged with: bethesda biotechnology diabetes diluted share revenue second quarter sports betting
Read More »